← Evidence map

ArticleBMC cancer2026

Benefits and challenges of adding BKM120 to a BI-3406 plus trametinib combination therapy.

Benjamin Schulz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42399819